PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsType 2 diabetes mellitus
MeSH D003924 - type 2 diabetes mellitus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003920:Diabetes mellitus
11 Companies
14 Drugs
$
Success rate
D003924: 
Type 2 diabetes mellitus
104 Companies
40 Drugs
$
Success rate
D003923:Lipoatrophic diabetes mellitus
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaGlimepiride Glimepiride  2005-10-06   
Metformin, Glipizide Glipizide Metformin  2005-10-28   
Glyburide Glyburide  1995-08-29   
Metformin, Glyburide Glyburide Metformin  2005-01-27   
Metformin Metformin  2002-01-24   
Nateglinide Nateglinide  2009-09-09   
Pioglitazone Pioglitazone  2014-01-10   
Metformin, Pioglitazone Pioglitazone Metformin  2014-03-10   
Pioglitazone Pioglitazone Teva  2012-03-26   
Pioglitazone Pioglitazone Teva Pharma  2012-03-26   
Repaglinide Repaglinide Teva  2009-06-28   
Glimepiride, Rosiglitazone Rosiglitazone Glimepiride  2016-04-01   
Metformin, Rosiglitazone Rosiglitazone Metformin  2014-05-07   
Novast LaboratoriesMetformin Metformin  2018-11-02   
PadagisRepaglinide Repaglinide  2013-07-17   
Glenmark PharmaceuticalsColesevelam Colesevelam  2018-07-16   
Metformin Metformin  2008-05-23   
Saxagliptin Saxagliptin  2023-07-31   
MylanCHLORPROPAMIDE Chlorpropamide  1984-06-01   
Glimepiride Glimepiride  2006-02-10   
Glipizide Glipizide  1995-06-20   
Metformin Metformin  2002-01-29   
Pioglitazone Pioglitazone  2012-08-17   
Metformin, Pioglitazone Pioglitazone Metformin  2011-02-25   
Repaglinide Repaglinide  2013-08-23   
Insulin glargine Semglee  2020-06-11   
Metformin, Sitagliptin Sitagliptin / Metformin Mylan  2022-02-16   
Tolbutamide Tolbutamide  1982-01-01   
Saxagliptin Saxagliptin  2023-07-31   
Metformin, Saxagliptin Saxagliptin Metformin  2023-07-31   
NATCO PharmaGlyburide Glyburide  1998-06-26   
TOLAZAMIDE Tolazamide  1986-01-02   
BioconInsulin glargine Semglee  2021-07-28   
Johnson & JohnsonMetformin, Canagliflozin Invokamet 2024-07-30 2014-08-08   
Canagliflozin Invokana 2025-04-11 2013-03-29   
Metformin, Canagliflozin Vokanamet  2014-04-23   
GSKAlbiglutide Eperzan  2014-03-20   
Albiglutide Tanzeum  2014-04-15   
CiplaColesevelam Colesevelam  2020-04-20   
Linagliptin Linagliptin  2024-09-03   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
78%
113/145
Phase 2
69%
137/200
Phase 3
77%
165/215
Approved: 55Overall Success rate: 41%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Glyburide,
Metformin,
Metformin glycinate,
Metformin hydrochloride
AstraZeneca
Metformin,
Dapagliflozin,
Exenatide,
Saxagliptin,
Metformin hydrochloride,
Pramlintide,
Metformin glycinate,
Angiotensin ii,
Benzocaine,
Gliclazide,
Antithrombin iii,
Enoblituzumab,
Ademetionine,
Tesaglitazar,
Doconexent,
Voglibose,
Tilarginine,
Sodium chloride,
Sodium lactate,
ALVELESTAT,
Aspartame,
Bevifimod,
COTADUTIDE,
Nadide,
Telbermin,
Tiratricol,
VERINURAD,
Microcrystalline cellulose,
Triglycerides, medium-chain,
AZD1656,
Glyclazide,
Lovaza,
Omacor,
Diluent,
Endocrine,
Manitol,
Mct,
Tzd,
Viaject,
AZD8601,
Ccb,
Epanova,
Glimepirde,
Azd5658,
Lyspro,
Sglt2,
Ufh,
Farxiga,
Gluconorm,
Solumedrol,
Arm1,
Azd6370,
Azd6714,
Rdx5791,
Arm2,
Bolus,
D5w,
Apelin,
AZD4017,
Azd8329,
Evidence,
Kcl,
Mydfrin
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use